Edoardo Conticini

4.6k total citations · 1 hit paper
82 papers, 1.2k citations indexed

About

Edoardo Conticini is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Edoardo Conticini has authored 82 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Rheumatology, 32 papers in Pulmonary and Respiratory Medicine and 20 papers in Epidemiology. Recurrent topics in Edoardo Conticini's work include Vasculitis and related conditions (24 papers), Inflammatory Myopathies and Dermatomyositis (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers). Edoardo Conticini is often cited by papers focused on Vasculitis and related conditions (24 papers), Inflammatory Myopathies and Dermatomyositis (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers). Edoardo Conticini collaborates with scholars based in Italy, United Kingdom and Spain. Edoardo Conticini's co-authors include Bruno Frediani, Dario Caro, Bruno Frediani, Luca Cantarini, Paolo Falsetti, Elena Bargagli, Miriana d’Alessandro, Caterina Baldi, Marco Bardelli and Paolo Cameli and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Environmental Pollution.

In The Last Decade

Edoardo Conticini

75 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?

2020 642 citations Edoardo Conticini, Bruno Frediani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edoardo Conticini Italy	13	383	332	285	196	190	82	1.2k
Bruno Frediani Italy	20	383 1.0×	333 1.0×	123 0.4×	389 2.0×	190 1.0×	67	1.9k
Sae Ochi Japan	17	139 0.4×	53 0.2×	72 0.3×	285 1.5×	24 0.1×	56	1.7k
Pi Guo China	24	39 0.1×	632 1.9×	124 0.4×	30 0.2×	116 0.6×	83	2.4k
Ming Xue China	17	35 0.1×	61 0.2×	116 0.4×	22 0.1×	27 0.1×	61	1.0k
Chunfang Wang China	20	183 0.5×	380 1.1×	56 0.2×	12 0.1×	17 0.1×	66	1.4k
Xiaodong Mei China	16	221 0.6×	488 1.5×	133 0.5×	6 0.0×	15 0.1×	36	986
Soon‐Hee Jung South Korea	15	117 0.3×	739 2.2×	294 1.0×	14 0.1×	15 0.1×	43	1.4k
Sara Gale United States	18	17 0.0×	209 0.6×	119 0.4×	378 1.9×	7 0.0×	34	1.1k
Emilio Gianicolo Italy	19	14 0.0×	216 0.7×	146 0.5×	26 0.1×	37 0.2×	86	979

Countries citing papers authored by Edoardo Conticini

Since Specialization

Citations

This map shows the geographic impact of Edoardo Conticini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Conticini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Conticini more than expected).

Fields of papers citing papers by Edoardo Conticini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edoardo Conticini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Conticini. The network helps show where Edoardo Conticini may publish in the future.

Co-authorship network of co-authors of Edoardo Conticini

This figure shows the co-authorship network connecting the top 25 collaborators of Edoardo Conticini. A scholar is included among the top collaborators of Edoardo Conticini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edoardo Conticini. Edoardo Conticini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rizzo, Chiara, Edoardo Conticini, Hector Chinoy, et al.. (2025). Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast. Reumatismo. 77(2). 1 indexed citations

Conticini, Edoardo, et al.. (2024). Impact of non-immunosuppressive medical therapy on disease progression and complications of Takayasu arteritis: A narrative review. Autoimmunity Reviews. 23(12). 103656–103656. 2 indexed citations

d’Alessandro, Miriana, Edoardo Conticini, Laura Bergantini, et al.. (2024). Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease. Tissue and Cell. 90. 102516–102516.

Caffarelli, Carla, et al.. (2024). The Advantages of Radiofrequency Echographic MultiSpectrometry in the Evaluation of Bone Mineral Density in a Population with Osteoarthritis at the Lumbar Spine. Diagnostics. 14(5). 523–523. 7 indexed citations

Falsetti, Paolo, Caterina Baldi, Edoardo Conticini, et al.. (2024). Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms. PubMed. 3(4). 277–287. 1 indexed citations

Conticini, Edoardo, et al.. (2024). Idiopathic inflammatory myopathies: one year in review 2023. Clinical and Experimental Rheumatology. 42(2). 213–224. 6 indexed citations

Baldi, Caterina, Simone Parisi, Paolo Falsetti, et al.. (2024). Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study. Journal of Clinical Medicine. 13(2). 401–401. 5 indexed citations

Conticini, Edoardo, Paolo Falsetti, Giovanni Biasi, et al.. (2024). Safety and Efficacy of Long-Term Tocilizumab in a Cohort of Patients with Giant Cell Arteritis: An Italian Monocentric Retrospective Study. Biologics. Volume 18. 297–305.

d’Alessandro, Miriana, Paolo Cameli, Caroline Cotton, et al.. (2024). Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease. PLoS ONE. 19(10). e0311357–e0311357. 2 indexed citations

10.

Porcelli, Brunetta, Miriana d’Alessandro, Latika Gupta, et al.. (2023). Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study. Biomedicines. 11(7). 1963–1963. 3 indexed citations

11.

Geest, Kornelis S. M. van der, Edoardo Conticini, Jo Jackson, et al.. (2023). POS0737 AGE AND SEX BIAS OF ULTRASOUND SCORES FOR DIAGNOSIS OF GIANT CELL ARTERITIS: INSIGHTS FROM THE PROSPECTIVE, LONGITUDINAL HAS-GCA STUDY. Annals of the Rheumatic Diseases. 82. 657–658.

12.

D’Alessandro, Roberto, Paolo Falsetti, Edoardo Conticini, et al.. (2023). Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography. Life. 13(2). 487–487. 5 indexed citations

13.

Conticini, Edoardo, Paolo Falsetti, Miriana d’Alessandro, et al.. (2023). Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study. Biologics. Volume 17. 151–160. 5 indexed citations

14.

d’Alessandro, Miriana, Laura Bergantini, Paolo Cameli, et al.. (2022). Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. International Journal of Environmental Research and Public Health. 19(4). 2176–2176. 6 indexed citations

15.

Falsetti, Paolo, Edoardo Conticini, Caterina Baldi, et al.. (2022). Diffuse Peripheral Enthesitis in Metabolic Syndrome: A Retrospective Clinical and Power Doppler Ultrasound Study. Reumatología Clínica (English Edition). 18(5). 273–278. 2 indexed citations

16.

D’Alessandro, Roberto, Edoardo Conticini, Paolo Falsetti, et al.. (2022). Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study. Reumatologia/Rheumatology. 60(5). 326–331. 1 indexed citations

17.

Conticini, Edoardo, Miriana d’Alessandro, Chiara Rizzo, et al.. (2022). Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study. Clinical and Experimental Rheumatology. 41(2). 285–290. 3 indexed citations

18.

Conticini, Edoardo, Jurgen Sota, Paolo Falsetti, et al.. (2021). Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review. Autoimmunity Reviews. 20(4). 102784–102784. 8 indexed citations

19.

Frediani, Bruno, Paolo Falsetti, Alberto Migliore, et al.. (2020). Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study. Drugs in R&D. 20(1). 39–45. 18 indexed citations

20.

Capochiani, Enrico, Bruno Frediani, Giorgio Iervasi, et al.. (2020). Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol. Frontiers in Medicine. 7. 466–466. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact